These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 279963)

  • 1. A critique of animal models in antibiotic research.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):109-17. PubMed ID: 279963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of models for the therapy of experimental infections.
    Bergeron MG
    Scand J Infect Dis Suppl; 1978; (14):189-206. PubMed ID: 279972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocompromised animal models for the study of antibiotic combinations.
    Calandra T; Glauser MP
    Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of therapy in animal models to bacterial infection in human disease.
    Tunkel AR; Scheld WM
    Infect Dis Clin North Am; 1989 Sep; 3(3):441-59. PubMed ID: 2504810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin in animal models of infection.
    Andriole VT
    Am J Med; 1987 Apr; 82(4A):67-70. PubMed ID: 3555064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of the experimental model of bacterial endocarditis].
    Carbon C
    Bull Acad Natl Med; 1995 Apr; 179(4):767-74; discussion 775-6. PubMed ID: 7648311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis.
    Carbon C
    Scand J Infect Dis Suppl; 1990; 74():163-72. PubMed ID: 2097705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibiotic sensitivity testing breakpoints and therapeutic activity in induced infections in animal models.
    Soriano F; Aguilar L; Ponte C
    J Chemother; 1997 May; 9 Suppl 1():36-46. PubMed ID: 9248961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening infections: how to choose the right antibiotics.
    Smith IM; Habte-Gabr E
    Geriatrics; 1977 Mar; 32(3):83-6. PubMed ID: 844691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimalization of antibiotic policy in the Netherlands. VII. SWAB-guidelines for antimicrobial therapy in adults patients with infectious endocarditis].
    Verhagen DW; van der Feltz M; Plokker HW; Buiting AG; Tjoeng MM; van der Meer JT;
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2417-21. PubMed ID: 14694550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial resistance after antibiotic use in animals--impact on human health].
    Sundsfjord A; Sunde M
    Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2457-61. PubMed ID: 19096469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the antibiotic guidelines in The Netherlands. VII. SWAB guidelines for antimicrobial therapy in adult patients with infectious endocarditis.
    Verhagen DW; van der Feltz M; Plokker HW; Buiting AG; Tjoeng MM; van der Meer JT;
    Neth J Med; 2003 Dec; 61(12):421-9. PubMed ID: 15025420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of infectious endocarditis].
    Blatter M; Frei R; Zimmerli W
    Praxis (Bern 1994); 1994 Nov; 83(47):1324-31. PubMed ID: 7991950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental staphylococcal endocarditis: an overview.
    Gutschik E
    Scand J Infect Dis Suppl; 1983; 41():87-94. PubMed ID: 6589765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic therapy of infectious endocarditis (when, with what drug, how long?].
    Schuler G
    Z Kardiol; 1994 Jan; 83(1):2-8. PubMed ID: 8147065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.